Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Frontiers in Pharmacology
|
June 3, 2022
Vancomycin, Daptomycin, Antistaphylococcal β-Lactam, and Trimethoprim-Sulfamethoxazole Monotherapy and Combination Therapy in the Management of Methicillin-Resistant <i>Staphylococcus aureus</i>: A Network Meta-Analysis
Xiaonan Xu, Ni Lu, Pan Song, et al.
Clinical & Translational Immunology
|
January 15, 2024
A phase II study to evaluate the safety and efficacy of anlotinib combined with toripalimab for advanced biliary tract cancer
Mingzhen Zhou, Yuncheng Jin, Sihui Zhu, et al.
Cancer Biology & Medicine
|
August 9, 2023
Regulatory role of exosomes in colorectal cancer progression and potential as biomarkers
Juan Hui, Mingzhen Zhou, Guangzhou An, et al.
Frontiers in Oncology
|
July 16, 2026
LAG3-centered multiplex immune profiling as a prognostic biomarker in hepatocellular carcinoma patients receiving Anti-PD-1 antibodies plus lenvatinib therapy
Juan Zhang, Mingzhen Zhou, Ziyue Jin, et al.
BMC Cancer
|
July 7, 2024
KK-LC-1, a biomarker for prognosis of immunotherapy for primary liver cancer
Sihui Zhu, Yuncheng Jin, Mingzhen Zhou, et al.
Head & Neck
|
December 31, 2013
Prognostic model for distant metastasis in locally advanced nasopharyngeal carcinoma after concurrent chemoradiotherapy
Chuangzhen Chen, Siqia Chen, Quynh-Thu Le, et al.
Cancer Medicine
|
November 6, 2023
Survival benefit and biomarker of PD-1 inhibitor combination therapy in first-line of advanced biliary tract cancer: A retrospective study
Jingyi Guo, Qun Zhou, Mingzhen Zhou, et al.
Asian Journal of Surgery
|
April 19, 2021
Transperitoneal versus retroperitoneal approaches of pyeloplasty in management of ureteropelvic junction obstruction: A meta-analysis
Pan Song, Mengxuan Shu, Zhufeng Peng, et al.
Journal of Hepatocellular Carcinoma
|
February 13, 2024
Lymphocyte-to-C Reactive Protein Ratio is an Independent Predictor of Survival Benefits for Hepatocellular Carcinoma Patients Receiving Radiotherapy
Zhan Shi, Sihui Zhu, Yuncheng Jin, et al.
Hepatobiliary Surgery and Nutrition
|
November 7, 2024
A novel nomogram for predicting the prognosis of hepatocellular carcinoma patients following immune checkpoint inhibitors treatment beyond progression: a single center study based on Chinese population
Chao Chen, Xiaoyuan Chu, Hong Liu, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Frontiers in Pharmacology
|
June 3, 2022
Vancomycin, Daptomycin, Antistaphylococcal β-Lactam, and Trimethoprim-Sulfamethoxazole Monotherapy and Combination Therapy in the Management of Methicillin-Resistant <i>Staphylococcus aureus</i>: A Network Meta-Analysis
Xiaonan Xu, Ni Lu, Pan Song, et al.
Clinical & Translational Immunology
|
January 15, 2024
A phase II study to evaluate the safety and efficacy of anlotinib combined with toripalimab for advanced biliary tract cancer
Mingzhen Zhou, Yuncheng Jin, Sihui Zhu, et al.
Cancer Biology & Medicine
|
August 9, 2023
Regulatory role of exosomes in colorectal cancer progression and potential as biomarkers
Juan Hui, Mingzhen Zhou, Guangzhou An, et al.
Frontiers in Oncology
|
July 16, 2026
LAG3-centered multiplex immune profiling as a prognostic biomarker in hepatocellular carcinoma patients receiving Anti-PD-1 antibodies plus lenvatinib therapy
Juan Zhang, Mingzhen Zhou, Ziyue Jin, et al.
BMC Cancer
|
July 7, 2024
KK-LC-1, a biomarker for prognosis of immunotherapy for primary liver cancer
Sihui Zhu, Yuncheng Jin, Mingzhen Zhou, et al.
Head & Neck
|
December 31, 2013
Prognostic model for distant metastasis in locally advanced nasopharyngeal carcinoma after concurrent chemoradiotherapy
Chuangzhen Chen, Siqia Chen, Quynh-Thu Le, et al.
Cancer Medicine
|
November 6, 2023
Survival benefit and biomarker of PD-1 inhibitor combination therapy in first-line of advanced biliary tract cancer: A retrospective study
Jingyi Guo, Qun Zhou, Mingzhen Zhou, et al.
Asian Journal of Surgery
|
April 19, 2021
Transperitoneal versus retroperitoneal approaches of pyeloplasty in management of ureteropelvic junction obstruction: A meta-analysis
Pan Song, Mengxuan Shu, Zhufeng Peng, et al.
Journal of Hepatocellular Carcinoma
|
February 13, 2024
Lymphocyte-to-C Reactive Protein Ratio is an Independent Predictor of Survival Benefits for Hepatocellular Carcinoma Patients Receiving Radiotherapy
Zhan Shi, Sihui Zhu, Yuncheng Jin, et al.
Hepatobiliary Surgery and Nutrition
|
November 7, 2024
A novel nomogram for predicting the prognosis of hepatocellular carcinoma patients following immune checkpoint inhibitors treatment beyond progression: a single center study based on Chinese population
Chao Chen, Xiaoyuan Chu, Hong Liu, et al.
Page
of 3